Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IVIg dose-frequency response trial in CIDP maintenance treatment
2012-005150-34Phase 4Completed
- Sponsor
- Erasmus MC
- Start
- Jul 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of immune globulin in chronic inflammatory demyelinating polyneuropathy (CIDP) and acute-onset chronic inflammatory demyelinating polyradiculoneuropathy (A-CIDP) (2 arms), sponsored by Erasmus MC. Primary endpoint: Change from baseline in hand grip strength. Started Jul 2014; status: completed.
02
Drugs
immune globulin
03
Conditions
chronic inflammatory demyelinating polyneuropathy (CIDP)acute-onset chronic inflammatory demyelinating polyradiculoneuropathy (A-CIDP)
Beyond the preview
Go deeper on 2012-005150-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-005150-34.